Kristin L. Butterfield

Statistics

Publications

Citations

128

H-Index

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kristin L. Butterfield is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, neuropharmacology, and pharmacy.

Publications per year

2009–2016

Publications

Equivalent Dynamic Human Brain NK1-Receptor Occupancy Following Single-Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging

Koen Van Laere, Jan de Hoon, Guy Bormans et al. · Clinical Pharmacology & Therapeutics · 2012 · 44 citations

Medicine, Nuclear Medicine, Pharmacology +13

Effects of 13-Hour Hyperglucagonemia on Energy Expenditure and Hepatic Glucose Production in Humans

Manu V. Chakravarthy, Stephanie A. Parsons, Michael E. Lassman et al. · Diabetes · 2016 · 28 citations · Full text

Life Sciences, Endocrinology, Physiology +17

Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir

Rajesh Krishna, Lilly East, Patrick Larson et al. · Journal of Pharmacy and Pharmacology · 2016 · 25 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Effect of Telcagepant on Spontaneous Ischemia in Cardiovascular Patients in a Randomized Study

Martin O. Behm, Rebecca Blanchard, M. Gail Murphy et al. · Headache The Journal of Head and Face Pain · 2011 · 20 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

The pharmacokinetics and tolerability of telcagepant, a novel calcitonin gene related peptide (CGRP) receptor antagonist, in healthy subjects and migraineurs

Han Th, RL Blanchard, John Palcza et al. · Ghent University Academic Bibliography (Ghent University) · 2009 · 11 citations

Medicine, Pharmacokinetics, Pharmacology +12

1–5 of 5